Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Apr 18;13:2377–2394. doi: 10.2147/IJN.S158536

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 Zhang et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Effect of Ova-related complexes on antigen-presenting cells.

Notes: (A) Macrophage proliferation; (B) macrophage phagocytosis; (C) proportion of F4/80⁺ macrophages; (D) proportion of CD11c⁺ splenocytes; (E) proportion of CD11c⁺CD40⁺ splenocytes; (F) proportion of CD11c⁺ CD86⁺ splenocytes; (G) proportion of CD11c⁺ MHCII⁺ splenocytes. *P<0.05, **P<0.01, ***P<0.001 compared to PBS control; ^#P<0.05, ^##P<0.01, ^###P<0.001 compared to Ova control; ^!P<0.05, ^!!P<0.01, ^!!!P<0.001 compared to the Ova + AL control (n=3).

Abbreviations: CS, curdlan sulfate; O-HTCC, O-(2-hydroxyl)propyl-3-trimethyl ammonium chitosan chloride; Ova, ovalbumin; AL, Alhydrogel; MHC, major histocompatibility complex.